- Design
- Single-centre retrospective case-control study
- Population
- 62 prostate cancer patients with germline pathogenic variants and 246 sporadic controls
- Primary outcome
- Clinical, MRI and pathological characteristics
- Effect
- PI-RADS 5 OR 2.7 (1.5 to 4.9); upgrading at prostatectomy 37% vs 20%
A single-centre case-control study compared 62 men with prostate cancer and a germline pathogenic variant — most often CHEK2, BRCA2, ATM or Lynch syndrome genes — with 246 consecutive sporadic cases, all with MRI at diagnosis.
Carriers were not significantly younger. Almost all had a positive MRI in both groups. But carriers more often had a PI-RADS 5 lesion (OR 2.7, 95% CI 1.5 to 4.9) and grade 3 extraprostatic extension (OR 3.0, 1.5 to 5.8), and were more often upgraded at prostatectomy (37% vs 20%).
This is a small retrospective study, and carriers referred for genetic testing may differ from those who are not. It supports reading carefully for extraprostatic extension when a germline variant is known.
- Ask whether a germline pathogenic variant is known when reporting a prostate MRI for staging.
- Look carefully for extraprostatic extension in known carriers, where it was more frequent.
- Mention in the report when a known carrier's biopsy grade may understate the MRI appearance.
- Do not treat this as evidence on screening carriers; it describes men already diagnosed.
Why it matters
It suggests biopsy grade may understate disease in carriers, so imaging should weigh more in staging.
Don't overread it
A small single-centre case-control study; it does not show that MRI screening benefits carriers.
The statistics, in plain English
An odds ratio of 2.7 for PI-RADS 5 means carriers' lesions were scored 5 considerably more often. With 62 carriers, the intervals are wide and the upgrade difference (P = 0.046) is only just statistically significant.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for radiology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free